https://www.frontiersin.org/journals/endocrinology RSS Feed for Frontiers in Endocrinology | New and Recent Articles en-us Frontiers Feed Generator,version:1 2026-05-13T08:31:28.121+00:00 60 https://www.frontiersin.org/articles/10.3389/fendo.2026.1833684 https://www.frontiersin.org/articles/10.3389/fendo.2026.1833684 2026-05-13T00:00:00Z Review Pengbo RenJian ZhangShi LiTingwen Li https://www.frontiersin.org/articles/10.3389/fendo.2026.1872081 https://www.frontiersin.org/articles/10.3389/fendo.2026.1872081 2026-05-13T00:00:00Z Correction Frontiers Production Office https://www.frontiersin.org/articles/10.3389/fendo.2026.1805525 https://www.frontiersin.org/articles/10.3389/fendo.2026.1805525 2026-05-13T00:00:00Z Original Research Junjia ShaoXia LiLifeng WangBo Dong https://www.frontiersin.org/articles/10.3389/fendo.2026.1758519 https://www.frontiersin.org/articles/10.3389/fendo.2026.1758519 2026-05-13T00:00:00Z Original Research Xiang MaoWenhua LiuBingqian HuEnguo Xu https://www.frontiersin.org/articles/10.3389/fendo.2026.1838301 https://www.frontiersin.org/articles/10.3389/fendo.2026.1838301 2026-05-13T00:00:00Z Systematic Review Dongmei ZhangHongbo ZhouXiujuan YangDajian Xia 1000 but not in smaller studies.ConclusionsThis meta-analysis demonstrates inconsistent associations between diabetes and mortality in AECOPD patients, which may be confounded by methodological factors and study design. Current evidence does not support diabetes as an independent risk factor for mortality in AECOPD. Further well-designed, adequately powered prospective cohort studies with rigorous adjustment for confounders are warranted to clarify the true prognostic impact of diabetes on AECOPD patients.]]> https://www.frontiersin.org/articles/10.3389/fendo.2026.1764227 https://www.frontiersin.org/articles/10.3389/fendo.2026.1764227 2026-05-13T00:00:00Z Original Research Ling ZhangBin TangYaqian QinXuan LuJia TangAiling Peng https://www.frontiersin.org/articles/10.3389/fendo.2026.1865319 https://www.frontiersin.org/articles/10.3389/fendo.2026.1865319 2026-05-13T00:00:00Z Editorial Konstantinos Dafopoulos https://www.frontiersin.org/articles/10.3389/fendo.2026.1791850 https://www.frontiersin.org/articles/10.3389/fendo.2026.1791850 2026-05-13T00:00:00Z Original Research Yang WuJie LiuYu YangKun ChenFei HuaKun Wang https://www.frontiersin.org/articles/10.3389/fendo.2026.1736419 https://www.frontiersin.org/articles/10.3389/fendo.2026.1736419 2026-05-13T00:00:00Z Original Research Haiyan GaoLibo XuWenjuan LiuHaibo LiBin SunWei LiZhengqin WuBeihong ZhengYibing Zhu https://www.frontiersin.org/articles/10.3389/fendo.2026.1816340 https://www.frontiersin.org/articles/10.3389/fendo.2026.1816340 2026-05-13T00:00:00Z Original Research Jie GaoYiran Li 0.05 for protocol switch strategies).ConclusionsPhenotype-driven “quantity” or “quality” rescue is associated with significant clinical improvements following ART failure while keeping Gn dosages constant. While tactical switching is effective, a substantial proportion of the success in a second attempt is driven by natural biological variation (regression to the mean).”]]> https://www.frontiersin.org/articles/10.3389/fendo.2026.1815903 https://www.frontiersin.org/articles/10.3389/fendo.2026.1815903 2026-05-13T00:00:00Z Case Report Elise Van der BorghtBart Van der SchuerenRoman VangoitsenhovenDavid CassimanBaris AkinciRebecca J. BrownElif A. OralAnn MertensPieter-Jan Martens 20-year follow-up of two sisters with CGL type 1 (AGPAT2 deficiency, OMIM# 608594), enrolled in early metreleptin trials. Clinical outcomes, adherence, immunogenicity, and pregnancies were assessed. Both cases showed rapid and sustained metabolic improvement after metreleptin initiation, allowing insulin discontinuation and triglyceride normalization. Menstrual cycles resumed within six months; allowing both to carry successful pregnancies while continuing metreleptin. Both cases experienced reduced treatment adherence over time, linked to psychological distress. One case developed both anti-drug antibodies and neutralizing activity through immune based assay after 14 years, but without significant clinical impact. In conclusion, these cases highlight both the sustained metabolic benefits of therapy and the complex challenges that may arise over time, such as antibody formation and difficulties in maintaining long-term adherence. Documentation of unmet medical needs can provide guidance and impetus for improved therapeutic approaches to achieve optimum quality of life.]]> https://www.frontiersin.org/articles/10.3389/fendo.2026.1836392 https://www.frontiersin.org/articles/10.3389/fendo.2026.1836392 2026-05-13T00:00:00Z Original Research Yiyi WangQilong ZhaiXuemei LianLei Zhao https://www.frontiersin.org/articles/10.3389/fendo.2026.1775998 https://www.frontiersin.org/articles/10.3389/fendo.2026.1775998 2026-05-13T00:00:00Z Original Research Dong HuTing HuangDongyang WuQinshuo ZhaoKai ZhangYuanlin ZouXin GuoYi Zhou 0.05). The predictive capacity of LAR for assessing LVA risk exceeded that of both lactate dehydrogenase and albumin (P< 0.05). Subgroup analyses further reinforced the robustness of these findings.ConclusionAn elevated LAR was independently associated with an increased risk of LVA development in patients with STEMI who underwent primary PCI.]]> https://www.frontiersin.org/articles/10.3389/fendo.2026.1843370 https://www.frontiersin.org/articles/10.3389/fendo.2026.1843370 2026-05-13T00:00:00Z Systematic Review Shan GaoFuyong ZhangXingxing XieLing Fan https://www.frontiersin.org/articles/10.3389/fendo.2026.1825381 https://www.frontiersin.org/articles/10.3389/fendo.2026.1825381 2026-05-12T00:00:00Z Original Research Puren GokbulutCagatay Emir OnderSerife Mehlika KuskonmazHuseyin YagcıCavit CulhaGonul Koc https://www.frontiersin.org/articles/10.3389/fendo.2026.1819985 https://www.frontiersin.org/articles/10.3389/fendo.2026.1819985 2026-05-12T00:00:00Z Original Research Kanagavalli RamasubbuDevi Rajeswari V. https://www.frontiersin.org/articles/10.3389/fendo.2026.1832788 https://www.frontiersin.org/articles/10.3389/fendo.2026.1832788 2026-05-12T00:00:00Z Original Research Pengfei GuBeibei ZhangZiliang DingYukun WeiYahui SunPengzhao SongWeiwei ZouYong HanFengli Guo https://www.frontiersin.org/articles/10.3389/fendo.2026.1764330 https://www.frontiersin.org/articles/10.3389/fendo.2026.1764330 2026-05-12T00:00:00Z Original Research Tetsuya MiyamotoVeronika MojikHubert Amrein https://www.frontiersin.org/articles/10.3389/fendo.2026.1845611 https://www.frontiersin.org/articles/10.3389/fendo.2026.1845611 2026-05-12T00:00:00Z Original Research Doudou LiYacong BoYao ChenZhitian GuoLi LiWenjie ZhangMingyi XueYongjian ZhuLiuhang RenTingting LiZhan Gao https://www.frontiersin.org/articles/10.3389/fendo.2026.1827041 https://www.frontiersin.org/articles/10.3389/fendo.2026.1827041 2026-05-12T00:00:00Z Systematic Review Yuan FangChunhua LiuZixin HeYongfei ZhengLing ZhuZhi Ye